Akums announces its entry into nutraceutical gummies segment

Akums Drugs and Pharmaceutical Limited has declared its entry into the nutraceutical gummies market with a new line of formulations for wellness and prevalent ailments. This effort aims to address a variety of conditions by providing a solution for adults, children, and the elderly who are looking for an alternative to traditional dosage forms such as tablets, capsules, syrup, and so on and who no longer find pills/capsules/syrups palatable or convenient.

The gummy products are tailored to address general wellness and nutritional needs, with choices ranging from multivitamins for children and immunity boosters to those that support hair health, PMS balance, urinary health, morning sickness, and sleep, among other things. There are also gummies that help with eye health, weight reduction, and anti-hangovers. Adult MVM and immunity therapies are also available, as are children's multivitamins and immunity, vitamin D, hair care (Biotin), UTI gummies, gut health, sleep support, and many other items.

"The modern lifestyle is hectic and leaves the consumer with less time to concentrate on health," said Sandeep Jain, Jt Managing Director, Akums. Imagine going about your everyday activities while taking nutraceuticals in the form of gummies." This viewpoint was shared by Sanjeev Jain, Jt Managing Director, Akums, who stated that drug non-compliance by patients has become a major issue across a variety of ailments and diseases, primarily because people do not find the drugs they are given easy to consume. "Our entry into the gummies sector is to demonstrate to our clients that we are up to date on current trends, and we want to offer nutraceuticals that people enjoy taking because they are tasty, convenient, and effective," he explained.

The move is also targeted at children, a demography known as picky eaters. The gummies have been creatively formulated and designed so that children can take their nutrition with ease. Within this year the company will also be expanding its R&D and manufacturing facility to introduce next-gen gummies.